Artículos por temáticas

Shining a light on posterior cortical atrophy

Crutch SJ, Schott JM, Rabinovici GD, Boeve BF, Cappa SF, Dickerson BC, Dubois B, Graff-Radford NR, Krolak-Salmon P, Lehmann M, Mendez MF, Pijnenburg Y, Ryan NS, Scheltens P, Shakespeare T, Tang-Wai DF

Alzheimers Dement. 2013 Jul;9(4):463-5. doi: 10.1016/j.jalz.2012.11.004. Epub 2012 Dec 28.

Enhancing the salience of fluency improves recognition memory performance in mild Alzheimer's disease

Bastin C, Willems S, Genon S, Salmon E.

J Alzheimers Dis. 2013;33(4):1033-9. doi: 10.3233/JAD-2012-121678.

C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease

Chapman RM, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, DeGrush E, Reilly LA.

J Alzheimers Dis. 2013;33(1):55-68. doi: 10.3233/JAD-2012-120646.

[Posterior variant of Alzheimer's disease and other atypical symptom pictures]

Remes AM, Vanninen R, Jokinen H, Hallikainen M, Erkinjuntti T.

Duodecim. 2013;129(3):244-50.

[Memorandum: of the problems of society with uncooperative and peculiar elderly persons. The right of the elderly to autonomy]

Schützendorf E.

Pflege Z. 2013 Apr;66(4):244-7.

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging

Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Murali Doraiswamy P, Carpenter AP, Clark CM, Joshi AD, Lu M, Grundman M, Mintun

Alzheimers Dement. 2013 Oct;9(5 Suppl):S72-83. doi: 10.1016/j.jalz.2012.10.007. Epub 2013 Jan 30.

Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year

Winchester J, Dick MB, Gillen D, Reed B, Miller B, Tinklenberg J, Mungas D, Chui H, Galasko D, Hewett L, Cotman CW.

Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):96-103. doi: 10.1016/j.archger.2012.06.016. Epub 2012 Sep 5.

Has inhibition of Aβ production adequately been tested as therapeutic approach in mild AD? A model-based meta-analysis of γ-secretase inhibitor data

Niva C, Parkinson J, Olsson F, van Schaick E, Lundkvist J, Visser SA.

Eur J Clin Pharmacol. 2013 Jun;69(6):1247-60. doi: 10.1007/s00228-012-1459-3. Epub 2013 Jan 4.

"Will I get Alzheimer disease?" when cognitively normal patients ask to be tested for Alzheimer disease

Snider BJ, Buckles VD.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):470-4. doi: 10.1212/01.CON.0000429171.50686.07.

[Step by step to a better well-being]

Günther C.

Krankenpfl Soins Infirm. 2013;106(9):15-7.

A passive positioning alarm used by persons with dementia and their spouses--a qualitative intervention study

Olsson A, Engström M, Lampic C, Skovdahl K.

BMC Geriatr. 2013 Feb 5;13:11. doi: 10.1186/1471-2318-13-11.

[The potential role for sphingolipids in neuropathogenesis of Alzheimer's disease]

Alesenko AV.

Biomed Khim. 2013 Jan-Feb;59(1):25-50.

[White lies in nursing patients with advanced dementia: "your husband has gone fishing"!]

Sachweh S.

Pflege Z. 2013 Feb;66(2):114-8.

[Assessment of mild cognitive impairment and dementia in epidemiologic studies. An overview on the current state of research in Germany]

Then FS, Luck T, Jacobi F, Berger K, Weyerer S, Grabe HJ, Busch MA, Wagner M, Riedel-Heller SG.

Psychiatr Prax. 2013 May;40(4):183-91. doi: 10.1055/s-0033-1343138. Epub 2013 Apr 5.

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response

Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R.

BMC Geriatr. 2013 Jun 6;13:56. doi: 10.1186/1471-2318-13-56.